Azarga

Azarga Therapeutics is a clinical-stage biopharmaceutical company based in Fort Worth, Texas, specializing in the development of innovative ophthalmic treatments. Founded by a team of industry veterans, including former executives from Alcon, the company focuses on addressing unmet needs in ocular health through proprietary drug delivery solutions. Azarga's primary focus is on developing sustained-release formulations and fixed-dose combinations designed to improve therapeutic outcomes and patient adherence for conditions such as glaucoma and ocular hypertension. By optimizing the delivery of established pharmacological agents, the company aims to reduce the treatment burden associated with traditional topical eye drop regimens.